Volume 14, Number 10—October 2008
Research
Estimating Community Incidence of Salmonella, Campylobacter, and Shiga Toxin–producing Escherichia coli Infections, Australia
Table 4
Condition/severity category | Symptom multiplier† (95% CrI) | No. reported cases in severity category, in hundreds (95% CrI) | No. cases in the community for every 100 reported‡ (95% CrI) |
---|---|---|---|
Salmonellosis | |||
With blood | |||
1–2 d | 11.39 (8.49–16.36) | 1 (0–3) | 12.7 (0.8–32.1) |
3–4 d | 2.82 (2.17–3.98) | 7 (5–10) | 19.9 (12.6–30.9) |
> 5 d | 1.81 (1.33–2.72) | 42 (37–47) | 76.6 (54.3–116.0) |
Without blood | |||
1–2 d | 143.29 (83.30–371.0) | 2 (1–4) | 282.6 (50.4–870.3) |
3–4 d | 13.06 (6.37–67.83) | 7 (5–10) | 91.8 (40.3–533.5) |
>5 d | 3.93 (2.10–11.92) | 41 (36–46) | 160.8 (85.8–513.8) |
Overall | 100 | 695 (399–1,643) | |
Campylobacteriosis | |||
With blood | |||
1–2 d | 12.40 (9.16–17.82) | 2(1–3) | 24.8 (16.3–38.6) |
3–4 d | 3.06 (2.32–4.33) | 8(6, 10) | 24.3 (15.8–36.9) |
>5 d | 1.97 (1.42–2.95) | 34 (31, 37) | 67.92 (48.5–106.3) |
Without blood | |||
1–2 d | 154.17 (89.31–397.59) | 3 (2–4) | 475.7 (250.6–1,234.3) |
3–4 d | 14.15 (6.80–73.32) | 10 (8–12) | 139.0 (68.7–739.7) |
>5 d | 4.25 (2.25–13.36) | 43 (40–46) | 183.4 (97.9–578.1) |
Overall | 100 | 1001 (664–2,251) | |
STEC in South Australia | |||
With blood | |||
1–2 d | 13.02 (9.50–18.37) | 0 | 0 |
3–4 d | 3.13 (2.36–4.45) | 18 (6–30) | 51.6 (16.2–101.2) |
>5 d | 2.02 (1.47–3.04) | 68 (50–87) | 123.5 (74.9–212.9) |
Without blood | |||
1–2 d | 157.18 (61.67–218.75) | 3 (1–5) | 432.5 (142.4–1,220.1) |
3–4 d | 14.35 (7.38–64.34) | 6(1–11) | 78.0 (13.6–400.1) |
>5 d | 4.31 (2.27–13.44) | 6 (1–11) | 2-3.0 (2.67–91.7) |
Overall | 13.02 (9.50–18.37) | 100 | 815 (330–7,514) |
*STEC, Shiga toxin–producing Esherichia coli.
†Number of cases in the community for every notification.
‡Product of previous 2 columns.
Page created: July 13, 2010
Page updated: July 13, 2010
Page reviewed: July 13, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.